Literature DB >> 31395131

Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week.

Filippos Triposkiadis1, Andrew Xanthopoulos1, Javed Butler2.   

Abstract

Heart failure (HF) is a clinical syndrome that usually develops in the elderly. Complex interactions of the cardiovascular aging process with risk factors (obesity, hypertension, and atherosclerosis), comorbidities (anemia, chronic kidney disease, diabetes, and so on), and disease modifiers (sex, genes, others) contribute to the development of HF phenotype and outcome. A conglomerate of cellular and molecular mechanisms underlies the effects of aging on cardiovascular function, the most important being excessive oxidative stress and chronic low-grade inflammation superimposed on the limited cardiac regeneration capacity. Notably, a sizeable percentage of elderly HF patients have cardiac amyloidosis, an HF precipitator. This review summarizes the current published data on the mechanisms of cardiovascular aging as they contribute to the development of HF phenotype and outcome.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aging; amyloidosis; comorbidities; heart failure; risk factors

Mesh:

Year:  2019        PMID: 31395131     DOI: 10.1016/j.jacc.2019.06.053

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

Review 1.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

2.  Critical values of monitoring indexes for perioperative major adverse cardiac events in elderly patients with biliary diseases.

Authors:  Zong-Ming Zhang; Xi-Yuan Xie; Yue Zhao; Chong Zhang; Zhuo Liu; Li-Min Liu; Ming-Wen Zhu; Bai-Jiang Wan; Hai Deng; Kun Tian; Zhen-Tian Guo; Xi-Zhe Zhao
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

Review 3.  Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.

Authors:  Manhal Izzy; Brett E Fortune; Marina Serper; Nicole Bhave; Andrew deLemos; Juan F Gallegos-Orozco; Cesar Guerrero-Miranda; Shelley Hall; Matthew E Harinstein; Maria G Karas; Michael Kriss; Nicholas Lim; Maryse Palardy; Deirdre Sawinski; Emily Schonfeld; Anil Seetharam; Pratima Sharma; Jose Tallaj; Darshana M Dadhania; Lisa B VanWagner
Journal:  Am J Transplant       Date:  2022-03-31       Impact factor: 9.369

4.  Assessment of Diastolic Function and Thiol-Disulphide Homeostasis in Arsenic-Exposed Workers.

Authors:  Ugur Nadir Karakulak; Ceylan Bal; Meside Gunduzoz; Murat Buyuksekerci; Elifcan Aladag; Mehmet Levent Sahiner; Ergun Baris Kaya; Necla Ozer; Omer Hinc Yilmaz; Ozcan Erel
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

5.  G-MDSCs promote aging-related cardiac fibrosis by activating myofibroblasts and preventing senescence.

Authors:  Shu-Ning Sun; Shi-Hao Ni; Yue Li; Xin Liu; Jian-Ping Deng; Zi-Xin Chen; Huan Li; Wen-Jun Feng; Yu-Sheng Huang; Da-Nian Li; Shao-Xiang Xian; Zhong-Qi Yang; Ling-Jun Wang; Lu Lu
Journal:  Cell Death Dis       Date:  2021-06-08       Impact factor: 8.469

Review 6.  Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers.

Authors:  Filippos Triposkiadis; Andrew Xanthopoulos; John Parissis; Javed Butler; Dimitrios Farmakis
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 7.  Left ventricular hypertrophy and sudden cardiac death.

Authors:  Grigorios Giamouzis; Apostolos Dimos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2021-06-28       Impact factor: 4.214

Review 8.  New Developments in Exosomal lncRNAs in Cardiovascular Diseases.

Authors:  Zhu Yuan; Weiqiang Huang
Journal:  Front Cardiovasc Med       Date:  2021-07-08

9.  Transcriptome features of striated muscle aging and predictability of protein level changes.

Authors:  Yu Han; Lauren Z Li; Nikhitha L Kastury; Cody T Thomas; Maggie P Y Lam; Edward Lau
Journal:  Mol Omics       Date:  2021-10-11

10.  LuQi Formula Regulates NLRP3 Inflammasome to Relieve Myocardial-Infarction-Induced Cardiac Remodeling in Mice.

Authors:  Xiaoqing Zhang; Dandan Zhao; Jiling Feng; Xiaoli Yang; Zhenzhen Lan; Tao Yang; Xiaoni Kong; Huiyan Qu; Hua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.